Interestingly, Pd-l1 (Cd274) was also upregulated (Figure 1C), consistent with the induction of adaptive immune resistance mechanisms following local immune activation [17] and anti-tumor immunity (Figure 1C). The gene discussed is CD274; the disease is neoplasm.